ABBV Jun 2024 200.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:36PM EDT. Market open.
Loading interactive chart…
- Zacks
Top Analyst Reports for Oracle, AbbVie & Lowe's
Today's Research Daily features new research reports on 16 major stocks, including Oracle Corporation (ORCL), AbbVie Inc. (ABBV) and Lowe's Companies, Inc. (LOW).
- Zacks
Is It Worth Investing in AbbVie (ABBV) Based on Wall Street's Bullish Views?
The average brokerage recommendation (ABR) for AbbVie (ABBV) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
- Zacks
AbbVie's (ABBV) Epcoritamab Gets Approval in Europe for DLBCL
Tepkinly is AbbVie's (ABBV) second hematological cancer drug to be approved in the European Union. It is also the third blood cancer medicine in AbbVie's portfolio
© 2023 Yahoo. All rights reserved.
